Tuazon, Noriel T.
HRN: 21-78-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2022
CEFUROXIME 1.5GM (VIAL)
09/19/2022
09/19/2022
IV
1.5g
SD
Surgical Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes